文献速递免疫规划

AF03佐剂增强小鼠对已上市四价季节性流感疫苗诱导的抗血凝素和抗神经氨酸酶免疫应答

AF03 adjuvant improves anti-hemagglutinin and anti-neuraminidase immune responses induced by licensed seasonal quadrivalent influenza vaccines in mice.
PubMed 文献 · Vaccine · 2023-02-18

本研究在小鼠模型中评估水包油佐剂AF03对两种已上市四价流感疫苗(含HA和NA的标准剂量灭活疫苗IIV4-SD、仅含HA的重组疫苗RIV4)免疫原性的影响。AF03增强了针对全部四种同源疫苗株的功能性HA特异性抗体滴度,并提高针对同源HA、30种异源H3 HA和7种乙型流感HA的总IgG结合滴度;IIV4-SD-AF03组的神经氨酸酶抑制活性显著更高。

要点

  • AF03佐剂增强小鼠对IIV4-SD和RIV4两种四价流感疫苗的功能性HA特异性抗体应答。
  • AF03提高针对同源HA、30种异源H3 HA及7种乙型流感HA的总IgG结合滴度。
  • IIV4-SD-AF03组的神经氨酸酶抑制活性显著高于对照。

核心结论

  • 在小鼠模型中,AF03佐剂通过提高针对NA和广谱HA抗原的功能性与总抗体应答,改善两种流感疫苗的免疫反应。

研究设计与样本

  • 在未免疫BALB/c小鼠模型中,将含HA和NA的标准剂量灭活四价流感疫苗(IIV4-SD)和仅含HA的重组四价流感疫苗(RIV4)分别以AF03佐剂配制后评估免疫原性。

主要发现

  • AF03增强了针对全部四种同源疫苗株的功能性HA特异性抗体滴度。
  • 检测到针对同源HA、30种异源H3 HA和7种乙型流感HA的HA特异性总免疫球蛋白G(IgG)结合滴度升高。
  • IIV4-SD-AF03组的神经氨酸酶抑制(NAI)活性显著更高。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Seasonal influenza remains a serious public health concern as the viral infection spreads easily from person to person and due to antigenic drift of neutralizing epitopes. Vaccination is the best method for disease prevention, however current seasonal influenza vaccines stimulate antibodies which are often effective against only antigenically similar strains. To boost the immune responses and increase vaccine effectiveness, adjuvants have been used for the past 20 years. The current study explores the use of oil-in-water adjuvant, AF03 to improve an immunogenicity of 2 licensed vaccines. A standard-dose inactivated quadrivalent influenza vaccine (IIV4-SD), containing both hemagglutinin (HA) and neuraminidase (NA) antigens, and recombinant quadrivalent influenza vaccine (RIV4), containing only HA-antigen were adjuvanted with AF03 in naïve BALB/c mouse model. Functional HA-specific antibody titers against all four homologous vaccine strains were enhanced by AF03, indicating potential increase in protective immunity. An increase in HA-specific total immunoglobulin G (IgG) binding titers were detected against homologous HAs, heterologous panel of 30 H3 HAs and seven Influenza B HAs. The neuraminidase inhibition (NAI) activity was significantly higher in IIV4-SD-AF03 group. Use of AF03 adjuvant improved the immune response to two influenza vaccines in a mouse model via an increase in functional and total antibodies against NA and a broad panel of HA-antigens.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Ustyugova IV, Pougatcheva S, Farrell T, et al. AF03 adjuvant improves anti-hemagglutinin and anti-neuraminidase immune responses induced by licensed seasonal quadrivalent influenza vaccines in mice. Vaccine. 2023. PMID: 36803901. doi:10.1016/j.vaccine.2023.02.034

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。